CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-09-24 | SIGMA TAU FINANZIARIA SPA 10% owner | Purchase | +3,952,569 | $0.25 | $1000K | 45,619,236 |
| 2009-09-24 | SIGMA TAU FINANZIARIA SPA 10% owner | Other acquisition · Common Stock Warrant (right to buy) | +1 | 1 | ||
| 2009-09-24 | CAVAZZA PAOLO 10% owner | Purchase | +3,952,569 | $0.25 | $1000K | 45,619,236 |
| 2009-09-24 | CAVAZZA PAOLO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2009-09-24 | CAVAZZA CLAUDIO 10% owner | Purchase | +3,952,569 | $0.25 | $1000K | 45,619,236 |
| 2009-09-24 | CAVAZZA CLAUDIO 10% owner | Other acquisition · Common Stock Warrant (warrant to buy) | +1 | 1 | ||
| 2009-09-18 | Biotex Pharma Investments, LLC 10% owner | Returned to the company | −250,000 | $0.27 | $66K | 18,750,000 |
| 2009-08-11 | Biotex Pharma Investments, LLC 10% owner | Sale | −500,000 | $0.20 | $100K | 19,000,000 |
| 2009-07-30 | Biotex Pharma Investments, LLC 10% owner | Sale | −500,000 | $0.20 | $102K | 19,500,000 |
| 2009-07-01 | SCHNITTKER CHRISTOPHER P VP ADMIN CONTROLLER | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2009-06-04 | Buhrman Cyrille F Director | Grant or award · Stock Options (right to buy) | +250,000 | 250,000 | ||
| 2009-06-04 | Lapointe Gregg Anthony Director | Grant or award · Stock Options (right to buy) | +37,500 | 37,500 | ||
| 2009-06-04 | KUO JAMES S Director | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2009-03-11 | Hamilton Brian L Chief Medical Officer | Grant or award · Stock Options (right to buy) | +1,000,000 | 1,000,000 | ||
| 2009-03-10 | Lapointe Gregg Anthony Director | Grant or award · Stock Options (right to buy) | +300,000 | 300,000 | ||
| 2009-02-11 | SIGMA TAU FINANZIARIA SPA 10% owner | Purchase | +25,000,000 | $0.18 | $4.5M | 41,666,667 |
| 2009-02-11 | CAVAZZA PAOLO 10% owner | Purchase | +25,000,000 | $0.18 | $4.5M | 41,666,667 |
| 2009-02-11 | CAVAZZA CLAUDIO 10% owner | Purchase | +25,000,000 | $0.18 | $4.5M | 41,666,667 |
| 2008-12-18 | Brey Robert N Chief Scientific Officer/SrVP | Grant or award · Stock Options (Right to Buy) | +800,000 | 800,000 | ||
| 2008-12-18 | SCHABER CHRISTOPHER J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,800,000 | 2,800,000 |
Page 16 of 22 · 422 trades